Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

This chart shows the share of people diagnosed with tuberculosis (TB) who were cured/completed their treatment, by TB type (in %)*.

Globally, tuberculosis is the most common bacterial infectious disease leading to death. The pathogen causing tuberculosis, Mycobacterium tuberculosis, has a number of peculiarities. One is that it is ...

Please provide your email address to receive an email when new articles are posted on . Linezolid successfully treated pregnant patients with multidrug-resistant tuberculosis, with most patients ...

Background. The success of the current treatment regimen for multidrug-resistant (MDR) tuberculosis is poor partly owing to a high default rate. Many studies have explored predictors of poor outcomes, ...

Please provide your email address to receive an email when new articles are posted on . Pregnant women treated with regimens including bedaquiline and/or delamanid had positive treatment outcomes.

An estimated 440 000 cases of multidrug-resistant tuberculosis (MDR TB) occurred worldwide in 2008 (3•6% of all TB cases that year), but only 7% of these cases were identified and treated. Extensively ...

Introduction Prior to 2020, treatment options for multidrug-resistant tuberculosis (MDR-TB) were limited and typically ...

Despite strong national programmes, late diagnosis, treatment gaps, private-sector fragmentation, and poor adherence remain ...

An outbreak of multidrug-resistant tuberculosis (TB) developed in Kansas in November 2021, and included multiple children who were born in the U.S. and became infected in the state, CDC researchers ...

The successful treatment of multidrug-resistant tuberculosis requires clarification in advance as to which antibiotics the pathogens are resistant to. Classic testing is very time-consuming and delays ...